Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
The global Biomarkers Market was valued at USD 27.91 billion in 2016 and is projected to reach USD 88.99 billion by 2025, growing at a CAGR of 13.75% from 2017 to 2025.
Biomarkers are of immense importance in biotech based research and genetic studies. With Increasing fund and interest of private and public players, the market is expected to grow at a high rate during the forecast period.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Increasing Diagnostic applications such as personalized medicine and companion diagnostics
1.2 Increasing funds for R&D
1.3 Increasing Number of Cros and Low Cost of Clinical Trials in Developing Countries
1.4 Increase in the number of cancer cases
1.5 Interests in Biomarker Research
2. Market Restraints
2.1 High Capital Investments and Low Cost-Benefit Ratio
2.2 Poorly Suited Regulatory and Reimbursement Systems
2.3 Technical Issues Related to Sample Collection and Storage
Market Segmentation:
1. Global BiomarkersMarket, by Disease Indication:
1.1 Cancer
1.2 Cardiovascular Disorders
1.3 Neurological Disorders
1.4 Immunological Disorders
1.5 Other Diseases
2. Global BiomarkersMarket, by Application:
2.1 Diagnostics
2.2 Drug Discovery and Development
2.3 Personalized Medicine
2.4 Disease Risk Assessment
2.5 Other Applications
3. Global Biomarkers Market, by Type:
3.1 Safety Biomarkers
3.2 Efficacy Biomarkers
3.2.1 Predictive Biomarkers
3.2.2 Surrogate Biomarkers
3.2.3 Pharmacodynamic Biomarkers
3.2.4 Prognostic Biomarkers
3.3 Validation Biomarkers
4. Global Biomarkers Market, by Product:
4.1 Consumables
4.2 Services
4.3 Software
5. Global Biomarkers Market, by Region:
5.1 North America (U.S., Canada, Mexico)
5.2 Europe (Germany, UK, France, Rest of Europe)
5.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
5.4 Latin America (Brazil, Argentina, Rest of Latin America)
5.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Qiagen N.V.
2. Perkinelmer, Inc.
3. Merck Millipore
4. Bio-Rad Laboratories, Inc.
5. Enzo Biochem, Inc.
6. EKF Diagnostics Holdings, Inc.
7. Meso Scale Diagnostics, LLC.
8. Biosims Technologies Sas
9. Cisbio Bioassays
10. Signosis, Inc
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the BiomarkersMarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
Request Sample 
Request Discount 
Inquire Before Buy
